Paragon Ventures

Paragon Ventures is a healthcare-focused M&A advisory firm that specializes in the merger, acquisition, and divestiture of private mid-market companies in the healthcare and life sciences sectors. Founded in 1994 by former healthcare business owners Marc S. Rose and Richard G. Davis, Jr., the firm has completed over 337 transactions across pharmacy distribution, home healthcare, respiratory care, infusion therapies, behavioral health, hospice, medical supply, and medical device sectors.

The firm's principals are former healthcare business owners who have personally experienced M&A transactions, bringing firsthand operational and exit strategy expertise. Paragon Ventures maintains offices across multiple U.S. locations including California, Boston North, Philadelphia, and Puerto Rico. The company has completed transactions in 45 U.S. states, with a buyer/investor database exceeding 7,700 contacts.

Paragon Ventures offers services spanning strategic exit planning, business valuation through their proprietary Market Pulse Analysis, confidential marketing processes, and transaction facilitation from initial planning through closing. In 2024, the firm celebrated its 30th anniversary serving the healthcare M&A market.

Choose Paragon Ventures when you need M&A advisors who understand healthcare operations from an owner's perspective. The firm's principals have built, grown, and sold their own healthcare businesses, providing practical guidance on navigating reimbursement complexities, regulatory requirements, and healthcare-specific due diligence issues that can impact valuations.

Expect a managed process from initial strategic planning and valuation through confidential marketing and transaction closing. The firm's healthcare-specific buyer database and 30-year history facilitating healthcare transactions position them to identify strategic and financial buyers who understand the unique aspects of healthcare business models.

Paragon Ventures operates exclusively within healthcare and life sciences, with specialized expertise across pharmacy distribution, home healthcare, respiratory care, infusion therapies, sleep therapy, nursing services, behavioral health, hospice, medical supply, and medical device sectors. The firm's understanding of healthcare reimbursement models, regulatory compliance requirements, and demographic trends informs their valuation methodologies and buyer identification strategies.

All principals have direct experience navigating Medicare regulations, payor relationships, and healthcare-specific operational challenges, having built businesses in sectors including home medical equipment, pharmacy services, infusion therapy, and behavioral health treatment centers.

The ideal client is an established, profitable mid-market healthcare company with revenues typically ranging from several million to mid-eight figures, operating in pharmacy services, home healthcare, medical distribution, or related healthcare sectors. Owners should be considering exit strategies or strategic acquisitions and value working with advisors who have personally experienced building and selling healthcare businesses.